Sanctuary Advisors LLC Trims Stock Holdings in Kenvue Inc. (NYSE:KVUE)

Sanctuary Advisors LLC cut its stake in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 2.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 531,773 shares of the company's stock after selling 13,117 shares during the quarter. Sanctuary Advisors LLC's holdings in Kenvue were worth $11,550,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. AMF Tjanstepension AB lifted its position in shares of Kenvue by 187.3% during the 3rd quarter. AMF Tjanstepension AB now owns 120,477 shares of the company's stock valued at $2,787,000 after acquiring an additional 78,540 shares during the last quarter. Vontobel Holding Ltd. lifted its position in shares of Kenvue by 13.4% during the 3rd quarter. Vontobel Holding Ltd. now owns 22,594 shares of the company's stock valued at $523,000 after acquiring an additional 2,677 shares during the last quarter. Capital Investment Advisors LLC lifted its position in shares of Kenvue by 11.9% during the 3rd quarter. Capital Investment Advisors LLC now owns 11,309 shares of the company's stock valued at $262,000 after acquiring an additional 1,201 shares during the last quarter. Everence Capital Management Inc. acquired a new stake in shares of Kenvue during the 3rd quarter valued at $473,000. Finally, Sequoia Financial Advisors LLC lifted its position in shares of Kenvue by 6.2% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 24,690 shares of the company's stock valued at $571,000 after acquiring an additional 1,449 shares during the last quarter. 97.64% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

KVUE has been the topic of a number of research reports. Canaccord Genuity Group dropped their price target on shares of Kenvue from $27.00 to $24.00 and set a "buy" rating on the stock in a research note on Friday, February 7th. Deutsche Bank Aktiengesellschaft downgraded shares of Kenvue from a "buy" rating to a "hold" rating and lowered their target price for the stock from $25.00 to $24.00 in a research report on Thursday, December 12th. UBS Group lowered their target price on shares of Kenvue from $23.00 to $21.00 and set a "neutral" rating on the stock in a research report on Friday, February 7th. Piper Sandler raised Kenvue from a "neutral" rating to an "overweight" rating and raised their price target for the company from $21.00 to $26.00 in a research report on Monday, January 6th. Finally, Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $24.00 price target on shares of Kenvue in a research report on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, Kenvue has an average rating of "Hold" and a consensus target price of $23.00.

Kenvue Stock Up 4.1 %

KVUE traded up $0.92 during trading on Friday, hitting $23.31. The company had a trading volume of 25,659,098 shares, compared to its average volume of 13,792,800. The firm's 50-day moving average price is $21.29 and its 200 day moving average price is $22.14. The company has a quick ratio of 0.69, a current ratio of 1.00 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a one year low of $17.67 and a one year high of $24.46. The company has a market capitalization of $44.68 billion, a PE ratio of 43.97, a PEG ratio of 2.61 and a beta of 1.45.

Kenvue (NYSE:KVUE - Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The company reported $0.26 earnings per share for the quarter, hitting the consensus estimate of $0.26. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. As a group, equities analysts expect that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, February 26th. Shareholders of record on Wednesday, February 12th will be given a $0.205 dividend. The ex-dividend date is Wednesday, February 12th. This represents a $0.82 dividend on an annualized basis and a yield of 3.52%. Kenvue's dividend payout ratio is currently 154.72%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.